Patent Assignment
Reel/Frame 017759/0882
Release of Security Interest
Recorded: 2006-06-12
Pages: 7
Assignor
BANK OF AMERICA, N.A.
Executed: 2005-12-15
Assignee
PUREPAC PHARMACEUTICAL CO.
200 ELMORA AVENUE, ELIZABETH, NEW JERSEY, 07207
Covered Properties
(6)
Transdermal Administration of Amines with Minimal Irritation and High Transdermal Flux Rate
Patent:
5,422,118 →
Application:
07/948,232 →
Controlled Absorption Diltiazem Pharmaceutical Formulation
Patent:
5,834,024 →
Application:
08/814,602 →
Controlled Absorption Diltiazem Pharmaceutical Formulation
Patent:
6,033,687 →
Application:
09/287,904 →
Pharmaceutical Composition Containing an Active Agent That Is Maintained in Solid Amorphous Form and Method of Making the Same
Application:
09/317,448 →
Pharmaceutical Tablet Formulation Containing Gabapentin with Improved Physical and Chemical Characteristics and Method of Making the Same
Patent:
6,294,198 →
Application:
09/379,604 →
Pharmaceutical Tablet Formulation Containing Gabapentin with Improved Physical and Chemical Characteristics and Method of Making the Same
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Feb 25, 1993
From: BROWN, LARRY R.; CLINE, JOHN F.; DAVIDSON, BETTY
To: PURE PAC, INC.
Reel/Frame 006473/0173 →
Assignment of Assignor's Interest
Jun 3, 1998
From: HEINICKE, GRANT WAYNE; LEPORE, ANGELO; MORELLA, ANGELO MARIO
To: FH FAULDING & CO., LIMITED
Reel/Frame 009262/0670 →
Assignment of Assignor's Interest
Jun 3, 1998
From: HEINICKE, GRANT WAYNE; LEPORE, ANGELO; MORELLA, ANGELO MARIO
To: FH FAULDING & CO. LIMITED
Reel/Frame 009254/0740 →
Assignment of Assignor's Interest
Jun 24, 1999
From: CHEN, JINLING; VILKOV, ZALMAN
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 010046/0226 →
Assignment of Assignor's Interest
Aug 24, 1999
From: VILKOV, ZALMAN
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 010203/0814 →
Assignment of Assignor's Interest
May 10, 2000
From: VILKOV, ZALMAN
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 010793/0715 →
Security Agreement
Feb 15, 2002
From: US ORAL PHARMACEUTICALS PTY LTD; PUREPAC PHARMACEUTICALS CO.; FAULDING PHARMACEUTICALS INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 012631/0017 →
Release of Security Interest
Nov 4, 2005
From: BANK OF AMERICA, N.A.
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 016722/0849 →
Security Agreement
Nov 10, 2005
From: ALPHARMA PHARMACEUTICALS INC.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016761/0701 →
Security Agreement
Nov 21, 2005
From: PUREPAC PHARMACEUTICAL CO.
To: BANK OF AMERICA, N.A., AS AGENT
Reel/Frame 016800/0368 →
Release of Security Interest
Nov 14, 2007
From: BANK OF AMERICA, N.A.
To: ALPHARMA PHARMACEUTICALS, INC.
Reel/Frame 020105/0257 →
Grant of Security Interest
Nov 28, 2007
From: ACTAVIS ELIZABETH LLC, A LIMITED LIABILITY COMPANY
To: DEUTSCHE BANK AG, LONDON BRANCH, AS SECURITY AGENT
Reel/Frame 020540/0425 →
Assignment of Assignor's Interest
Dec 6, 2007
From: VILKOV, ZALMON
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 020234/0739 →
Conversion
Feb 4, 2008
From: PUREPAC PHARMACEUTICAL CO.
To: ACTAVIS ELIZABETH LLC
Reel/Frame 020451/0919 →
Assignment of Assignor's Interest
Feb 4, 2008
From: F.H. FAULDING & CO. LIMITED
To: PUREPAC PHARMACEUTICAL CO.
Reel/Frame 020451/0871 →
Patent Security Agreement Supplement
Dec 10, 2010
From: ACTAVIS GROUP PTC EHF.
To: DEUTSCHE BANK AG, LONDON BRANCH
Reel/Frame 025463/0758 →
Release of Security Interest in Intellectual Property
Nov 1, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS GROUP PTC EHF
Reel/Frame 029227/0314 →
Release of Security Interest in Intellectual Property
Nov 1, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS ELIZABETH LLC
Reel/Frame 029229/0936 →
Release of Security Interest in Intellectual Property
Nov 1, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS GROUP LLC
Reel/Frame 029229/0836 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 029229, Frame 0836.
Dec 7, 2012
From: DEUTSCHE BANK AG, LONDON BRANCH
To: ACTAVIS ELIZABETH LLC
Reel/Frame 029459/0297 →